752 related articles for article (PubMed ID: 17909001)
1. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
2. The Fbxw7/hCdc4 tumor suppressor in human cancer.
Tan Y; Sangfelt O; Spruck C
Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
[TBL] [Abstract][Full Text] [Related]
3. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
[TBL] [Abstract][Full Text] [Related]
4. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
[TBL] [Abstract][Full Text] [Related]
5. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
[TBL] [Abstract][Full Text] [Related]
7. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
[TBL] [Abstract][Full Text] [Related]
8. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
[TBL] [Abstract][Full Text] [Related]
10. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
[TBL] [Abstract][Full Text] [Related]
11. Role of the ubiquitin ligase Fbw7 in cancer progression.
Cheng Y; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
[TBL] [Abstract][Full Text] [Related]
12. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.
Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O
Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106
[TBL] [Abstract][Full Text] [Related]
14. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
15. [Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis].
Huang HJ; Zheng F; Xu FP; Liu YH; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):214-6. PubMed ID: 23769449
[No Abstract] [Full Text] [Related]
16. The Role of FBXW7 in Gynecologic Malignancies.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
Cells; 2023 May; 12(10):. PubMed ID: 37408248
[TBL] [Abstract][Full Text] [Related]
17. FBXW7 and DNA copy number instability.
Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
[TBL] [Abstract][Full Text] [Related]
18. Loss of CDC4/FBXW7 in gastric carcinoma.
Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
[TBL] [Abstract][Full Text] [Related]
19. FBXW7: a critical tumor suppressor of human cancers.
Yeh CH; Bellon M; Nicot C
Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
